Related references
Note: Only part of the references are listed.Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Michael J. Doenhoff et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Identification of oxadiazoles as new drug leads for the control of schistosomiasis
Ahmed A. Sayed et al.
NATURE MEDICINE (2008)
Qinghaosu (Artemisinin): The price of success
N. J. White
SCIENCE (2008)
Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice
Luc Van Nassauw et al.
Travel Medicine and Infectious Disease (2008)
Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis Control
Robert Bergquist et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
The unacknowledged impact of chronic schistosomiasis
Charles H. King et al.
CHRONIC ILLNESS (2008)
Artemisinins and synthetic trioxolanes in the treatment of helminth infections
Jennifer Keiser et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
Advances in the discovery and development of trematocidal drugs
Jennifer Keiser et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
A new series of schistosomicide drugs, the alkylaminoalkanethiosulfuric acids, partially inhibit the activity of Schistosoma mansoni ATP diphosphohydrolase
Marcus Luiz Oliveira Penido et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Praziquantel derivatives I: Modification of the aromatic ring
Fiona Ronketti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Chemotherapy of schistosomiasis: present and future
Conor R. Caffrey
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species
Shu-Hua Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Design, synthesis, and in vivo evaluation of oxamniquine methacrylate and acrylamide prodrugs
Roberto Parise Filho et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Schistosomiasis mansoni: Novel chemotherapy using a cysteine protease inhibitor
Maha-Hamadien Abdulla et al.
PLOS MEDICINE (2007)
Innovative lead discovery strategies for tropical diseases
Solomon Nwaka et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk
Peter Steinmann et al.
LANCET INFECTIOUS DISEASES (2006)
Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria - A comprehensive pro-poor health policy and strategy for the developing world
Peter J. Hotez et al.
PLOS MEDICINE (2006)
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
CH King et al.
LANCET (2005)
Drug therapy: Effectiveness of antimalarial drugs
JK Baird
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection
MF Oliveira et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs
DR Brocks et al.
CLINICAL PHARMACOKINETICS (2003)
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal
A Danso-Appiah et al.
TRENDS IN PARASITOLOGY (2002)
Oral artemether for prevention of Schistosoma mansoni infection:: randomised controlled trial
J Utzinger et al.
LANCET (2000)
Antimicrobial activities of mefloquine and a series of related compounds
CM Kunin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
The prophylactic effects of artemether against Schistosoma japonicum infections
SH Xiao et al.
PARASITOLOGY TODAY (2000)